Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) · 6 days ago
Executive Director Clinical Development
Arcutis Biotherapeutics, Inc. is a pioneering medical dermatology company dedicated to revolutionizing the treatment of serious skin diseases. The Executive Director of Clinical Development will support the design and execution of the clinical development strategy and direct the implementation of clinical trials.
Responsibilities
Leads, develops, supports and implements clinical development program strategy for assigned programs
Develops translational strategy and endpoints for early-stage programs, and strategy and clinical endpoints to support late-stage programs through approval and launch
Leads activities relating to clinical study design, preparation of protocol synopses, clinical trials oversight, data analyses and written study reports
Supports publications and publication strategy
Collaborates with external partners and vendors, including Clinical Research Organizations (CROs)
Leads clinically focused regulatory documents
Provides medical input to Competent Authority and Ethics Committee/IRB communications
Initiates, develops, and maintains relationships with Key Opinion Leaders (KOLs) and investigators
Represents clinical functions to management, as needed
Other duties that may be assigned, e.g., business development, SOP development
Qualification
Required
Typically requires a Bachelor's degree in a scientific discipline and an advanced degree (eg, PharmD, RN, PhD, PA, MD)
Typically requires 10 years industry experience
Excellent leadership skills; track record leading successful teams and supervising staff
Exceptional performance working independently; Ability to both function as an independent problem-solver and thrive in a team environment
Seamless, exemplary performance in a team/matrix setting
Ability to work in a fast-paced, dynamic environment with very minimal supervision
Ability to adapt well under pressure; track record of excellent flexibility, pragmatism, and judgment
Ability to prioritize and manage multiple responsibilities simultaneously
Exemplary collaboration skills with the ability to work effectively with internal and external stakeholders
Strong sense of accountability
Excellent verbal and written communication skills, as well as interpersonal skills; ability to communicate appropriately and effectively to individuals across functions and organization levels
Adherence to highest ethical standards; consistent high integrity
Ability to receive and provide feedback in professional, respectful, constructive manner; Strong interpersonal awareness
Clinical / medical expertise and fluency, e.g., from prior patient care training or experience
Thorough and deep experience and expertise with submissions from pre-clinical through all clinical phases and product launch, including in leadership roles and with significant NDA experience
Foundation and fluency in statistics
Foundation and fluency in dermatologic conditions and dermatology trial assessments and design; subject matter expertise
Ability to be primary organization representative to key external parties, eg, KOLs, scientific meetings, advisory boards
Demonstrates pragmatism, with ability to consistently produce high quality results and navigate quickly and efficiently within matrix environment
Strengths in change management, conflict resolution, motivating teams, team building, building relationships
Drive for self-improvement; pride of ownership, takes responsibility, attention to detail
Travel may be required up to 10% of time worked
Preferred
Dermatology-specific experience and expertise is strongly preferred
Ex-North America experience strongly preferred
Company
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology.
Funding
Current Stage
Public CompanyTotal Funding
$833.5MKey Investors
SLR Capital PartnersHBM Healthcare InvestmentsOrbiMed
2024-02-28Post Ipo Equity· $150M
2023-10-19Post Ipo Equity· $100M
2022-08-02Post Ipo Equity
Leadership Team
Recent News
The Motley Fool
2025-12-14
2025-11-22
Company data provided by crunchbase